Lactams and uses thereof

Details Lactams and uses thereof Lactams and uses thereof

2009-01-26

2010-12-28

Kifle, Bruck (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Unsubstituted hydrocarbyl chain between the ring and the -c-...

Reexamination Certificate

active

07858776

ABSTRACT:
Compounds having the formula (I)pharmaceutical compositions containing them and their methods of use for the treatment of neurological disorders related to amyloid β protein production and neurological disorders such as Alzheimer's disease. These compounds inhibit γ secretase and thereby inhibit the production of amyloid β protein, thereby acting to prevent the formation of neurological deposits of amyloid protein.

REFERENCES:
patent: 5936065 (1999-08-01), Arrhenius et al.
patent: 6136834 (2000-10-01), Ohmoto et al.
patent: 7342007 (2008-03-01), Herzog et al.
patent: 2008/0311609 (2008-12-01), Greenberg et al.
patent: 90/09162 (1990-08-01), None
patent: 97/24339 (1997-07-01), None
patent: 98/17680 (1998-04-01), None
patent: 98/28268 (1998-07-01), None
patent: 99/67219 (1999-12-01), None
patent: 99/67220 (1999-12-01), None
patent: 99/67221 (1999-12-01), None
patent: 00/02903 (2000-01-01), None
patent: 00/07995 (2000-02-01), None
patent: 00/19210 (2000-04-01), None
patent: 01/68655 (2001-09-01), None
patent: 01/07234 (2001-10-01), None
patent: 2004/100958 (2004-11-01), None
United States Patent and Trademark Office, Office Action dated Jun. 25, 2007 from co-pending U.S. Appl. No. 10/549,271 (Patent No. 7,342,007).
Banzatti, Carlo et al., “Synthesis of phenyl-substituted 2H-3,4-dihydro-3-aminomethyl-1,4-benzoxazines. Intermediates for 1 H-2,3,3a,4-Tetrahydroimidazo-{5,1 -c][1,4]benzoxizan-1 -one derivatives. Part II,” J . Heterocyclic Chem. 1983, pp. 259-265, vol. 20.
Heinrikson, Robert L. “Secretases,” Encyclopedia of Biological Chemistry, Chapter 4, 2004, pp. 7-10, vol. 4, Elsevier Ltd., Oxford, UK.
Karim, A. et al., “Synthese d'aminophosphinephosphinites chiraux . Utilisation en reduction asymetrique catalytique,” J. Organometallic Chem., 1986, pp. 93-104, vol. 317(1).
Li, Yue-Ming et al., “Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1.,” Nature, 2000, pp. 689-694, vol. 405 (6787).
Lu, Xinbo et al., “Process development on the preparation of trans-(+)-2-methylaminocyclohexanol: a fascinating resolution example,” Org. Proc. R&D, 2001, pp. 184-185, vol. 5(2).
Marjaux, Els et al., “gamma-Secretase inhibitors: still in the running as Alzheimer's therapeutics,” Drug Discovery Today: Therapeutic Strategies, 2004, pp. 1-6, vol. 1(1).
Nitsch, Roger M., “Immunotherapy of Alzheimer Disease,” Alzheimer Dis Assoc Disord, 2004, pp. 185-189, vol. 18 (4).
Petersen, R.C. et al., “Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the America Academy of Neurology,” Neurology, 2001, pp. 1133-1142, vol. 56 (9).
Remington's Pharmaceutical Sciences, 17th ed., Mack Publishing Company, Easton, PA 1985, pp. 1418-1419.
Ritchie, Karen, et al., “Classification criteria for mild cognitive impairment: a population-based validation study,” Neurology, 2001, pp. 37-42, vol. 56(1).
Wolfe, Michael S. et al., “Secretase as a target for Alzheimer's disease,” Current Topics in Medicinal Chemistry, 2002, pp. 371-383, vol. 2 (4).

Affiliated with

Also associated with

Rating

Lactams and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lactams and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lactams and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4201695